|
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
|
5R01CA186338-04
|
$342,938
|
$342,938
|
LI, MIN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Yap and beta-catenin interactions in liver: Implications in Pathophysiology
|
5R01CA204586-03
|
$416,268
|
$416,268
|
MONGA, SATDARSHAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Yale Cancer Center NCTN
|
5U10CA180826-05
|
$700,035
|
$140,007
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Xenobiotic receptors
|
ZIA BC 005562
|
$1,240,094
|
$930,071
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
|
ZIA BC 005708
|
$531,469
|
$318,881
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Womens Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S3
|
$175,562
|
$31,601
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-05
|
$542,950
|
$81,443
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
$7,292
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
$20,047
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
$23,400
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
$257,400
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-05
|
$1,394,352
|
$139,435
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-03
|
$2,300,000
|
$2,300,000
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
Washington University Human Tumor Atlas Research Center
|
1U2CCA233303-01
|
$1,752,191
|
$578,223
|
DING, LI
|
WASHINGTON UNIVERSITY
|
|
VU PREDICT
|
1U24CA220325-01A1
|
$664,613
|
$664,613
|
MANNING, HENRY
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Vitamin D and colorectal cancer risk: an integrated molecular and genetic epidemiologic study
|
7R00CA207848-04
|
$165,808
|
$165,808
|
WARREN ANDERSEN, SHANEDA
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Vitamin D and colorectal cancer risk: an integrated molecular and genetic epidemiologic study
|
4R00CA207848-03
|
$19,074
|
$19,074
|
WARREN ANDERSEN, SHANEDA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Visualization and Epigenomic Characterization of Early Intestinal Tumorigenesis in Mice
|
5R01CA212374-02
|
$434,625
|
$434,625
|
LAIRD, PETER
|
VAN ANDEL RESEARCH INSTITUTE
|
|
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
|
5K07CA204201-03
|
$176,941
|
$176,941
|
ENZINGER, ANDREA
|
DANA-FARBER CANCER INST
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
3R01CA184456-03S2
|
$65,611
|
$65,611
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
5R01CA184456-03
|
$341,981
|
$341,981
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S1
|
$218,356
|
$8,734
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S2
|
$203,848
|
$8,154
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S3
|
$86,197
|
$3,448
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
5P30CA016059-37
|
$2,170,000
|
$86,800
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,186,781
|
$296,695
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
5R01CA181392-05
|
$497,934
|
$497,934
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-06
|
$503,410
|
$100,682
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
5U01CA200466-03
|
$1,563,388
|
$1,563,388
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study)
|
5R01CA154823-07
|
$641,991
|
$641,991
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$532,008
|
$53,201
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$532,008
|
$106,402
|
Hodge, James
|
CCR (NCI)
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$413,112
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$22,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$12,261
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$6,814
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$2,859
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Utilizing Precision Medicine to elucidate the mechanisms underpinning treatment efficacy
|
1K99CA230384-01
|
$107,860
|
$53,930
|
HOPKINS, BENJAMIN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Utilizing MEK Inhibition to Sensitize Microsatellite Stable Colorectal Cancer to Immune Checkpoint Therapy
|
1R01CA229259-01
|
$247,340
|
$247,340
|
LIEU, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
|
Utility of RAS mimetics to block oncogenic signaling in colorectal cancer
|
1R21CA227963-01
|
$221,198
|
$221,198
|
REDDY, E
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-05
|
$644,932
|
$64,493
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-05
|
$1,267,600
|
$126,760
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using Second Harmonic Generation to Predict Metastatic Outcome in Colon Adenocarcinoma
|
5R21CA208921-02
|
$167,475
|
$167,475
|
BROWN, EDWARD
|
UNIVERSITY OF ROCHESTER
|
|
Using markers to improve pancreatic cancer screening and surveillance
|
5U01CA210170-03
|
$954,328
|
$954,328
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Using Functional Genomics to Inform Gene Environment Interactions for Colorectal Cancer
|
3R01CA201407-02S1
|
$32,686
|
$32,686
|
PETERS, ULRIKE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Using functional genomics to inform gene environment interactions for colorectal cancer
|
3R01CA201407-03S1
|
$23,154
|
$23,154
|
PETERS, ULRIKE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Using functional genomics to inform gene environment interactions for colorectal cancer
|
5R01CA201407-03
|
$1,867,631
|
$1,867,631
|
PETERS, ULRIKE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Using Context to Improve Implementation of Evidenced-based Interventions for Colorectal Cancer Screening in Rural Primary Care (Precise CRC)
|
5K07CA211971-02
|
$170,636
|
$170,636
|
DAVIS, MELINDA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Using Big Data to Estimate the Effects of Complex Cost-Sharing Rules on Colorectal Cancer Screening and Patient Health
|
5R21CA219229-02
|
$205,694
|
$205,694
|
WHALEY, CHRISTOPHER
|
RAND CORPORATION
|
|
Use of Alternative Tobacco Products Among Homeless Youth
|
5R01CA204004-02
|
$291,072
|
$145,536
|
TUCKER, JOAN
|
RAND CORPORATION
|
Total relevant funding to Digestive Diseases for this search: $614,519,306
|